Where does Medicaroid Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Medicaroid Corporation ranks #4,422 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Medicaroid Corporation hold?

Medicaroid Corporation holds 80 US utility patents granted between 2018 and 2025, spanning 22 technology areas.

What is Medicaroid Corporation's Innovation Score?

Medicaroid Corporation has an Innovation Score of 55.4 out of 100 (top 7% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Medicaroid Corporation focus on?

Medicaroid Corporation's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 74 patents. Grants appear in 22 CPC subclasses total.

Is Medicaroid Corporation's patent grant rate increasing or decreasing?

Medicaroid Corporation's recent grant velocity is +2367% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Medicaroid Corporation's patents?

Medicaroid Corporation's patents average 18.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Medicaroid Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Medicaroid Corporation

USPTO PatentsView assignee record - 80 granted patents across 22 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Medicaroid ranks #4,422 of 49,997 tracked US assignees by granted-patent volume, with 80 patents across 22 technology areas.

#4,422
of 49,997 US assignees by volume: Top 7%
by Innovation Score (55.4/100): 18.5
avg claims per patent: +2367%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4422 · Foreign Corporation #4,422 · 80 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 80 grants
TOP-DECILE #4,422/49,997
PHOTO-FINISH Draka Comteq B V
CPC-FOCUS A61B · 22 areas
INNOV-PAR 55.4/100
CLAIMS-RICH 18.5 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +2367% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Draka Comteq B.V. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
B&R Industrial… · near

55
IEE International &… · near

55
Medicaroid · this assignee

55
Thermo Finnigan · near

55
OUR United · near

55
3D Lighting… · lowest

7

What this shows Medicaroid's Innovation Score is 55.4/100 (top 7% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Medicaroid's grants concentrate

Medicaroid Corporation is a focused PatentsView assignee: 22 CPC subclasses with 92.5% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2023 (22 grants) versus a trough of 1 in 2019. By volume, Medicaroid sits between Draka Comteq B.V. and Norma Germany GMBH.

Medicaroid's three-year grant acceleration

From 2019–2021 to 2022–2024, Medicaroid Corporation moved from 26 to 49 grants (1.89x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Draka Comteq B V

80
EIS

80
IGT Canada Soluti…

80
Livanova USA

80
Mitac Computing T…

80
Nihon Plast

80
Nippon Hoso Kyokai

80
Norma Germany

80
Medicaroid ◀

80

What this shows Medicaroid holds 80 patents at rank #4,422, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Medicaroid

By rank, the assignees closest to #4,422 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Medicaroid's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Medicaroid, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (55 here).

B&R Industrial Automation GmbH 55 IEE International Electronics & Engineering S.A. 55 Thermo Finnigan LLC 55 OUR United Corporation 55

Similar claim depth

Nearest assignees by average claims per patent (18.5 here).

CAE Inc. 18.5 avg CareFusion 2200, Inc. 18.5 avg Ancestry.com Operations Inc. 18.5 avg Galderma Research & Development 18.5 avg

Medicaroid's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

55 Top 7% higher than 93% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Medicaroid Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	2	2.5%
2019	1	1.3%
2020	8	10.0%
2021	17	21.3%
2022	19	23.8%
2023	22	27.5%
2024	8	10.0%
2025partial year	3	3.8%

Which technologies does Medicaroid Corporation patent most?

A61B - DIAGNOSIS; SURGERY; Identification 74

B25J - MANIPULATORS; Chambers Provided With Manipulation Devices 23

A61G - Transport, Personal Conveyances, OR Accommodation Specially Adapted FOR Patients OR Disabled Persons ; Operating Tables OR CHAIRS; Chairs FOR DENTISTRY; Funeral Devices 10

G05B - Control OR Regulating Systems IN GENERAL; Functional Elements OF Such SYSTEMS; Monitoring OR Testing Arrangements FOR Such Systems OR Elements 5

G06F - Electric Digital Data Processing 4

Y10S - Technical Subjects Covered BY Former Uspc Cross-reference ART Collections [XRACs] AND Digests 4

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 4

H04N - Pictorial Communication, e.g. Television 3

G06T - Image Data Processing OR Generation, IN General 3

B23P - Metal-working NOT Otherwise Provided FOR; Combined OPERATIONS; Universal Machine Tools 3

B23Q - Details, Components, OR Accessories FOR Machine Tools, e.g. Arrangements FOR Copying OR Controlling ; Machine Tools IN General Characterised BY THE Construction OF Particular Details OR COMPONENTS; Combinations OR Associations OF Metal-working Machines, NOT Directed TO A Particular Result 2

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 2

H02K - Dynamo-electric Machines 1

H02P - Control OR Regulation OF Electric Motors, Electric Generators OR Dynamo-electric CONVERTERS; Controlling Transformers, Reactors OR Choke Coils 1

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 1

Top 15 of 22 technology areas

Where it ranks

Overall rank by patents

#4,422

of 49,997 tracked assignees

Innovation Score

55.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Medicaroid Corporation's patent record in context - here's where to go next.

Medicaroid Corporation's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 92.5% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #4,422 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Medicaroid Corporation against Draka Comteq B.V., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 55.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.